
Interviews with scientists, physicians, industry experts and investors.
| Platform | Pricing | Only free issues | Publishes | Weekly | |
|---|---|---|---|---|---|
| Issues | 81 | Founded | 4 years ago | Last Issue | 4 months ago |
| Active | |||||

To the untrained eye, biomedical progress occurs in fits and starts –a series of “overnight successes” or abject failures. Trial results are announced, acquisitions are made, stock prices move and new drugs get to patients (or vanish into t...
Biotech is an industry of specialization: science, medicine, investing, business development, corporate finance. Each of these disciplines requires years of training. Career paths often appear linear: PhD to Postdoc to Professor. Associate...
Biotech investing is a bottom-up business. Biological mechanisms, preclinical data, GMP chemistry, toxicology, PK/PD, clinical trial designs, unmet need, competitive landscapes, commercialization. The details matter, and Buffett’s fundament...
Redundancy is engineered into human biology. Evolution has provided myriad fail-safes to prevent catastrophe. In our immune system multiple pattern recognition receptors can identify overlapping sets of pathogens and evoke an immune respons...
Natural catastrophes create “ecological opportunity.” With reduced competition, well-adapted species can colonize niches quickly – often to the detriment of other inhabitants.
With a touch of melodrama characteristic of t...
Subscribers, engagement, traffic and sponsorship for Biomarker .
| Subscribers | Engagement | 69 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
The writers behind this newsletter.
Neurology resident @Mass General Brigham | MSTP @Harvard Medical School | Alum @Harvard College
Fascinated about the future of life.
You can find recent issues that have been published by Biomarker on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Biomarker , simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Biomarker as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Biomarker using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like Biomarker . You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.